Continuous Renal Replacement Therapy for the Management of Acid-Base and Electrolyte Imbalances in Acute Kidney Injury

Johnston, 2004, Responding to tragic error: lessons from Foothills Medical Centre, CMAJ, 170, 1659, 10.1503/cmaj.1040713

Barletta, 2006, Medication errors and patient complications with continuous renal replacement therapy, Pediatr Nephrol, 21, 842, 10.1007/s00467-006-0049-y

Cole, 2003, The impact of lactate-buffered high-volume hemofiltration on acid-base balance, Intensive Care Med, 29, 1113, 10.1007/s00134-003-1812-1

Kierdorf, 1999, Lactate- or bicarbonate-buffered solutions in continuous extracorporeal renal replacement therapies, Kidney Int Suppl, S32, 10.1046/j.1523-1755.56.s72.17.x

Heering, 1999, The use of different buffers during continuous hemofiltration in critically ill patients with acute renal failure, Intensive Care Med, 25, 1244, 10.1007/s001340051052

Kovesdy, 2012, Significance of hypo- and hypernatremia in chronic kidney disease, Nephrol Dial Transplant, 27, 891, 10.1093/ndt/gfs038

Wendland, 2012, A proposed approach to the dialysis prescription in severely hyponatremic patients with end-stage renal disease, Semin Dial, 25, 82, 10.1111/j.1525-139X.2011.00981.x

Yessayan, 2014, Treatment of severe hyponatremia in patients with kidney failure: role of continuous venovenous hemofiltration with low-sodium replacement fluid, Am J Kidney Dis, 64, 305, 10.1053/j.ajkd.2014.01.451

Bender, 1998, Successful treatment of severe hyponatremia in a patient with renal failure using continuous venovenous hemodialysis, Am J kidney Dis, 32, 829, 10.1016/S0272-6386(98)70141-6

Vassallo, 2012, Successful management of severe hyponatraemia during continuous renal replacement therapy, Clin Kidney J, 5, 155, 10.1093/ckj/sfr170

Pozzoni, 2007, Effectiveness of sodium and conductivity kinetic models in predicting end-dialysis plasma water sodium concentration: preliminary results of a single-center experience, Hemodial Int, 11, 169, 10.1111/j.1542-4758.2007.00165.x

Di Filippo, 2001, How to determine ionic dialysance for the online assessment of delivered dialysis dose, Kidney Int, 59, 774, 10.1046/j.1523-1755.2001.059002774.x

Garred, 1997, Urea kinetic modeling for CRRT, Am J Kidney Dis, 30, S2, 10.1016/S0272-6386(97)90535-7

Marshall, 2002, Urea kinetics during sustained low-efficiency dialysis in critically ill patients requiring renal replacement therapy, Am J Kidney Dis, 39, 556, 10.1053/ajkd.2002.31406

Spital, 1989, The paradox of sodium's volume of distribution. Why an extracellular solute appears to distribute over total body water, Arch Intern Med, 149, 1255, 10.1001/archinte.1989.00390060009002

Blumberg, 1997, Plasma potassium in patients with terminal renal failure during and after haemodialysis; relationship with dialytic potassium removal and total body potassium, Nephrol Dial Transplant, 12, 1629, 10.1093/ndt/12.8.1629

Zehnder, 2001, Low-potassium and glucose-free dialysis maintains urea but enhances potassium removal, Nephrol Dial Transplant, 16, 78, 10.1093/ndt/16.1.78

Hou, 1989, Safety and efficacy of low-potassium dialysate, Am J Kidney Dis, 13, 137, 10.1016/S0272-6386(89)80132-5

Cullen, 1933, Electrolytes in human tissue: II. The electrolyte content of hearts and other tissues from cases with various diseases, J Biol Chem, 102, 415, 10.1016/S0021-9258(18)50176-9

Szamosfalvi, 2012, Sensors and hybrid therapies: a new approach with automated citrate anticoagulation, Blood Purif, 34, 80, 10.1159/000341644

Alexandridis, 2003, Aminoglycoside-induced reversible tubular dysfunction, Pharmacology, 67, 118, 10.1159/000067797

Blachley, 1981, Renal and electrolyte disturbances associated with cisplatin, Ann Intern Med, 95, 628, 10.7326/0003-4819-95-5-628

Ringden, 1994, Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin, Bone Marrow Transplant, 14, S10

Cardella, 1979, Role of dialysis in the treatment of severe hypercalcemia: report of two cases successfully treated with hemodialysis and review of the literature, Clin Nephrol, 12, 285

Gradwohl-Matis, 2015, Renal replacement therapy with regional citrate anticoagulation as an effective method to treat hypercalcemic crisis, ASAIO J, 61, 219, 10.1097/MAT.0000000000000186

Kindgen-Milles, 2008, Treatment of severe hypercalcemia using continuous renal replacement therapy with regional citrate anticoagulation, ASAIO J, 54, 442, 10.1097/MAT.0b013e31817dc3be

Bellomo, 2009, Intensity of continuous renal-replacement therapy in critically ill patients, N Engl J Med, 361, 1627, 10.1056/NEJMoa0902413

Palevsky, 2008, Intensity of renal support in critically ill patients with acute kidney injury, N Engl J Med, 359, 7, 10.1056/NEJMoa0802639

Jacob, 1971, Acute hemolytic anemia with rigid red cells in hypophosphatemia, N Engl J Med, 285, 1446, 10.1056/NEJM197112232852602

Ognibene, 1994, Ventricular tachycardia in acute myocardial infarction: the role of hypophosphatemia, South Med J, 87, 65, 10.1097/00007611-199401000-00014

Singhal, 1992, Prevalence and predictors of rhabdomyolysis in patients with hypophosphatemia, Am J Med, 92, 458, 10.1016/0002-9343(92)90740-3

Silvis, 1972, Paresthesias, weakness, seizures, and hypophosphatemia in patients receiving hyperalimentation, Gastroenterology, 62, 513, 10.1016/S0016-5085(72)80032-5

Agusti, 1984, Hypophosphatemia as a cause of failed weaning: the importance of metabolic factors, Crit Care Med, 12, 142, 10.1097/00003246-198402000-00012

Aubier, 1985, Effect of hypophosphatemia on diaphragmatic contractility in patients with acute respiratory failure, N Engl J Med, 313, 420, 10.1056/NEJM198508153130705

Chua, 2013, Phoxilium vs Hemosol-B0 for continuous renal replacement therapy in acute kidney injury, J Crit Care, 28, 884.e7, 10.1016/j.jcrc.2013.02.013

Broman, 2011, Phosphate-containing dialysis solution prevents hypophosphatemia during continuous renal replacement therapy, Acta Anaesthesiol Scand, 55, 39, 10.1111/j.1399-6576.2010.02338.x

Troyanov, 2004, Phosphate addition to hemodiafiltration solutions during continuous renal replacement therapy, Intensive Care Med, 30, 1662, 10.1007/s00134-004-2333-2

Dellinger, 2008, Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008, Crit Care Med, 36, 296, 10.1097/01.CCM.0000298158.12101.41

Kraut, 2001, Use of base in the treatment of severe acidemic states, Am J Kidney Dis, 38, 703, 10.1053/ajkd.2001.27688

Barton, 1991, Successful treatment of severe lactic acidosis by haemofiltration using a bicarbonate-based replacement fluid, Nephrol Dial Transplant, 6, 368, 10.1093/ndt/6.5.368

Kirschbaum, 1992, Lactic acidosis treated with continuous hemodiafiltration and regional citrate anticoagulation, Crit Care Med, 20, 349, 10.1097/00003246-199203000-00010

Hilton, 1998, Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis, QJM, 91, 279, 10.1093/qjmed/91.4.279

Barcenas, 1976, Metabolic alkalosis after massive blood transfusion. Correction by hemodialysis, JAMA, 236, 953, 10.1001/jama.1976.03270090047030

Flanigan, 1996, Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A, Am J Kidney Dis, 27, 519, 10.1016/S0272-6386(96)90162-6

Gupta, 2004, Regional citrate anticoagulation for continuous venovenous hemodiafiltration using calcium-containing dialysate, Am J Kidney Dis, 43, 67, 10.1053/j.ajkd.2003.09.014

Janssen, 1996, Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients, Kidney Int, 49, 806, 10.1038/ki.1996.112

Szamosfalvi, 2010, Automated regional citrate anticoagulation: technological barriers and possible solutions, Blood Purif, 29, 204, 10.1159/000245648

Cointault, 2004, Regional citrate anticoagulation in continuous venovenous haemodiafiltration using commercial solutions, Nephrol Dial Transplant, 19, 171, 10.1093/ndt/gfg488

Yessayan, 2015, Treatment of severe metabolic alkalosis with continuous renal replacement therapy: bicarbonate kinetic equations of clinical value, ASAIO J, 61, e20, 10.1097/MAT.0000000000000216

Kwun, 1983, Treatment of metabolic alkalosis with intravenous infusion of concentrated hydrochloric acid, Am J Surg, 146, 328, 10.1016/0002-9610(83)90408-7

Wagner, 1979, Treatment of metabolic alkalosis with intravenous hydrochloric acid, South Med J, 72, 1241, 10.1097/00007611-197910000-00008